{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:24:20Z","timestamp":1772627060618,"version":"3.50.1"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5981","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T22:10:40Z","timestamp":1468534240000},"page":"1923-1927","source":"Crossref","is-referenced-by-count":20,"title":["Cytomegalovirus Reactivation Induced Acute Hepatitis and Gastric Erosions in a Patient with Rheumatoid Arthritis under Treatment with an Anti-IL-6 Receptor Antibody, Tocilizumab"],"prefix":"10.2169","volume":"55","author":[{"given":"Takuya","family":"Komura","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"},{"name":"Disease Control and Homeostasis, Kanazawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Seishima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Yamato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichiro","family":"Kaji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Marukawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kagaya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoki","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Disease Control and Homeostasis, Kanazawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Unoura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 376: 1094-1108, 2010.","DOI":"10.1016\/S0140-6736(10)60826-4"},{"key":"2","unstructured":"2. Dasgupta B, Corkill M, Kirkham B, Gibson T, Panayi G. Serial estimation of interleukin-6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol 19: 22-25, 1992."},{"key":"3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","volume":"74","author":"T Kishimoto","year":"1989","unstructured":"3. Kishimoto T. The biology of interleukin-6. Blood 74: 1-10, 1989.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Liuzzi JP, Lichten LA, Rivera S, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA 102: 6843-6848, 2005.","DOI":"10.1073\/pnas.0502257102"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2: 619-626, 2006.","DOI":"10.1038\/ncprheum0338"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Oldfield V, Dhillon S, Plosker GL. Tocilizumab. Drugs 69: 609-632, 2009.","DOI":"10.2165\/00003495-200969050-00007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nam JL, Winthrop KL, van Vollenhoven RF, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 69: 976-986, 2010.","DOI":"10.1136\/ard.2009.126573"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for the treatment of rheumatoid arthritis. Lancet 370: 1861-1874, 2007.","DOI":"10.1016\/S0140-6736(07)60784-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev (7): CD008331, 2010.","DOI":"10.1002\/14651858.CD008331"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Matsuyama M, Suzuki T, Tsuboi H, et al. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman&apos;s disease. Intern Med 46: 771-774, 2007.","DOI":"10.2169\/internalmedicine.46.6262"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagashima T, Minota S. Long-term tocilizumab therapy in patients with rheumatoid arthritis and chronic hepatitis B. Rheumatology 47: 1838-1840, 2008.","DOI":"10.1093\/rheumatology\/ken384"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Feist E, Burmester GR. Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA? Nat Clin Pract Rheumatol 5: 128-129, 2009.","DOI":"10.1038\/ncprheum1005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20: 202-213, 2010.","DOI":"10.1002\/rmv.655"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Griffi T. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis 12: 790-798, 2012.","DOI":"10.1016\/S1473-3099(12)70197-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lang VR, Englbrecht M, Rech J, et al. Risk of infections in rheumatoid arthritis patients treated with tocilizumab. Rheumatology (Oxford) 51: 852-857, 2012.","DOI":"10.1093\/rheumatology\/ker223"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Saunders BM, Frank AA, Orme IM, Cooper AM. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to <i>Mycobacterium tuberculosis<\/i> infection. Infect Immun 68: 3322-3326, 2000.","DOI":"10.1128\/IAI.68.6.3322-3326.2000"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ozdemir E, St John LS, Gillespie G, et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8<sup>+<\/sup> T cells. Blood 100: 3690-3697, 2002.","DOI":"10.1182\/blood-2002-05-1387"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Murphy EA, Davis JM, Brown AS, Carmichael MD, Ghaffar A, Mayer EP. Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance. J Interferon Cytokine Res 28: 589-595, 2008.","DOI":"10.1089\/jir.2007.0103"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ogawa J, Harigai M, Akashi T, et al. Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanized anti-interleukin-6 receptor monoclonal antibody. Ann Rheum Dis 65: 1667-1669, 2006.","DOI":"10.1136\/ard.2006.054197"},{"key":"20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jbspin.2010.07.009","volume":"77","author":"Z Kubandova","year":"2010","unstructured":"20. Kubandova Z, Mathieu S, Pourtier C, Soubrier M. Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody. Joint Bone Spine 77: 623-624, 2010.","journal-title":"Joint Bone Spine","ISSN":"https:\/\/id.crossref.org\/issn\/1297-319X","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Roux C, Breuil V, Albert C, et al. Ophthalmic herpes zoster infection in patients with rheumatoid arthritis who were treated with tocilizumab. J Rheumatol 38: 399, 2011.","DOI":"10.3899\/jrheum.100737"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. van Duin D, Miranda C, Husni E. Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy. Emerg Infect Dis 17: 754-756, 2011.","DOI":"10.3201\/eid1706.101057"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kawada J, Iwata N, Kitagawa Y, Kimura H, Ito Y. Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab. Mod Rheumatol 22: 565-570, 2012.","DOI":"10.3109\/s10165-011-0552-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Singh JA, Wells GA, Christensen R, et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev (2): CD008794, 2011.","DOI":"10.1002\/14651858.CD008794.pub2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.5981\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:21:27Z","timestamp":1600906887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.5981\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5981","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}